Hemispherx Biopharma ab auf die Watchlist
Seite 1 von 2 Neuester Beitrag: 19.07.21 10:26 | ||||
Eröffnet am: | 19.09.19 21:49 | von: moneywork4. | Anzahl Beiträge: | 44 |
Neuester Beitrag: | 19.07.21 10:26 | von: Balu4u | Leser gesamt: | 16.461 |
Forum: | Hot-Stocks | Leser heute: | 2 | |
Bewertet mit: | ||||
Seite: < | 2 > |
https://www.benzinga.com/general/biotech/19/09/...-breakthrough-award
https://aimimmuno.com/pipeline/
AIM ImmunoTech Joins with ChinaGoAbroad for an Ampligen China Entry Against COVID-19, the New SARS-like Coronavirus Disease Epidemic
Thursday, February 27, 2020
https://www.accesswire.com/viewarticle.aspx?id=578078
https://old.nasdaq.com/de/symbol/aim/real-time
Man kann gute Gewinne bei Ausbrüchen machen, aber diese Aktie will langfristig nur nach unten.
March 9, 2020
AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19
… the prior studies of Ampligen in SARS-CoV-1 animal experimentation may predict similar protective effects against SARS-CoV-2.
… Ampligen stands out as the only drug tested that conferred a significant survival effect ...